SCHEMBL9906786

SCHEMBL9906786

COc1cc(/C=C\c2cccc(OP(=O)(O)O)c2OP(=O)(O)O)cc(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.59
CYP1A1 P04798 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP1B1 Q16678 2/20 0.52
INPPL1 O15357 1/20 0.50
INPP5B P32019 1/20 0.50
INPP5A Q14642 1/20 0.50
NFE2L2 Q16236 4/20 0.49
TUBB4A P04350 3/20 0.49
TUBB P07437 3/20 0.49
TUBA3C P0DPH7 3/20 0.49
TUBA1B P68363 3/20 0.49
TUBA4A P68366 3/20 0.49
TUBB4B P68371 3/20 0.49
TUBB3 Q13509 3/20 0.49
TUBB2A Q13885 3/20 0.49
TUBB8 Q3ZCM7 3/20 0.49
TUBA3E Q6PEY2 3/20 0.49
TUBA1A Q71U36 3/20 0.49
TUBA1C Q9BQE3 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxi-4503 SCHEMBL29370292 0.84 CYP1A1 (0.54) SRCCYP1A1CYP1A2CYP1B1TUBB4A
Oxi-4503 SCHEMBL12677563 0.84 CYP1A1 (0.54) SRCCYP1A1CYP1A2CYP1B1TUBB4A
SCHEMBL14175308 0.84 CYP1A1 (0.57) SRCCYP1A1CYP1A2CYP1B1TUBB4A
SCHEMBL14175295 0.84 CYP1A1 (0.57) SRCCYP1A1CYP1A2CYP1B1TUBB4A
SCHEMBL17145746 0.84 SRC (0.50) SRCCYP1A1CYP1A2CYP1B1INPPL1
SCHEMBL14175306 0.83 CYP1A1 (0.56) CYP1A1CYP1A2CYP1B1TUBB4ATUBB
Oxi-4503 SCHEMBL30934510 0.83 CYP1A1 (0.52) SRCCYP1A1CYP1A2CYP1B1TUBB4A
SCHEMBL14175305 0.82 TUBB1 (0.51) CYP1A1CYP1A2CYP1B1TUBB4ATUBB
SCHEMBL14175299 0.81 TUBB1 (0.50) CYP1A1CYP1A2CYP1B1TUBB4ATUBB
SCHEMBL14175309 0.80 CYP1A1 (0.48) CYP1A1CYP1A2CYP1B1INPPL1INPP5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198302-B2 Anticancer agent having a quinone, quinone prodrug, catechol or catechol prodrug moiety; free of combretastatin A-1 OXIGENE, INC. (US) 2012-06-12 US disclosed
US-7384925-B2 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) OXIGENE, INC. (US) 2008-06-10 US disclosed